5 Benefits of ESWT for Chronic Foot Pain
At Caring Podiatry, we know how debilitating chronic pain caused by foot problems can be for our Middlesex and Monmouth County patients. This kind of discomfort can make it difficult to wear shoes, walk, exercise, and perform simple daily tasks. We offer a highly effective breakthrough procedure that can help cure chronic pain. It’s called Extracorporeal Shock Wave Therapy (ESWT). This FDA-approved, non-invasive treatment has proven to be effective for several common conditions such as:
Achilles tendonitis
Heel spurs
Chronic plantar fasciitis
Chronic tendonitis of the feet
Benefits of ESWT
The success rate of ESWT is equal to or greater than traditional treatments—including surgery. It uses a focused acoustic wave carrying high energy which stimulates metabolism, enhances blood flow, and accelerates the healing process. This allows damaged tissue to regenerate and heal.
ESWT is safe. First developed in Europe, this technology has been approved by the FDA and is currently in use around the world. The equipment used to perform ESWT was designed with state-of-the-art engineering and a wealth of medical experience. Extensive clinical studies and tests have proven its safety and effectiveness.
Minimal or no side effects and requires no anesthesia. Some patients report minor discomfort that lasts for a few days following treatment. After the brief, 10–15-minute treatment patients can bear weight immediately and return to normal activity within a few days.
Fast results. Benefits of ESWT are often evident after only 3 treatments. Some patients experience pain relief immediately after their initial treatment but usually within four weeks there is relief from pain.
ESWT is performed in the foot doctor’s office. You can receive treatments right in our Monroe Township (609-860-9111) or Neptune (732-455-8700) office.
To find out if ESWT can relieve the pain you’re feeling due to a podiatric condition contact us and set up an appointment with one of our podiatrists, Andrew Schmierer, Craig Shapero, and Mark Fillari.